Align Technology | ALGN - Ordinary Share Capital


Align Technology reported $71.62M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
3M USD 521.57M 8.71M Mar/2026
Align Technology USD 71.62M 133K Mar/2026
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Bruker USD 152.22M 282K Mar/2026
Cardinal Health USD 235M 1000K Mar/2026
Charles River Laboratories USD 48.17M 1.05M Mar/2026
Cooper Companies USD 195.11M 14K Mar/2026
CVS Health USD 1.27B 2M Mar/2026
Danaher USD 707.7M 800K Mar/2026
Dentsply International USD 200.3M 700K Mar/2026
Dexcom USD 385.9M 1.1M Mar/2026
Henry Schein USD 114.42M 1.35M Mar/2026
Idexx Laboratories USD 79.24M 611K Mar/2026
Insulet USD 69.26M 1.08M Mar/2026
Integra LifeSciences USD 77.82M 69K Mar/2026
IQVIA Holdings USD 166.9M 2.7M Mar/2026
McKesson USD 280M 156M Dec/2025
Mettler Toledo International USD 20.25M 179.94K Mar/2026
Revvity USD 111.8M 1.57M Mar/2026
Solventum Corp USD 173.53M 40.79K Mar/2026
Stryker USD 382.98M 584K Mar/2026
Teleflex USD 44.26M 70K Mar/2026
Thermo Fisher Scientific USD 371.62M 4.09M Mar/2026
Veeva Systems USD 163.2M 1.18M Mar/2026
Waters USD 98.17M 89K Mar/2026
Zimmer Biomet Holdings USD 195.5M 2.68M Mar/2026
Zoetis USD 420.35M 4.58M Mar/2026